Aaron Boudreau
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Aaron Boudreau has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Daojing Wang
Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720; and
1 shared publicationFelipe C. Geyer
Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London SW3 6JB, United Kingdom
1 shared publicationJorge S. Reis-Filho
Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London SW3 6JB, United Kingdom
1 shared publicationKandice Tanner
Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720; and
1 shared publication- Mina J. Bissell
Lawrence Berkeley National Laboratory, Berkeley, CA
1 shared publication
Latest Publications
- 25 September 2013
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 110 (41) , E3937-E3944
14-3-3σ stabilizes a complex of soluble actin and intermediate filament to enable breast tumor invasion
Significance: We characterize a mechanism by which 14-3-3σ directs cell migration and tumor invasion through regulating cytoskeletal solubility and dynamics. Our data suggest that 14-3-3σ expression, rather than being a tumor suppressor, in fact, aids in breast tumor invasion at least in a subset of carcinomas. Our findings warrant further investigation into the role of this molecule in normal mammary gland and breast tumors and, indeed, in epithelial tissues and tumors where 14-3-3σ is expressed.
- 25 September 2013
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 110 (41) , E3937-E3944
14-3-3σ stabilizes a complex of soluble actin and intermediate filament to enable breast tumor invasion
Significance: We characterize a mechanism by which 14-3-3σ directs cell migration and tumor invasion through regulating cytoskeletal solubility and dynamics. Our data suggest that 14-3-3σ expression, rather than being a tumor suppressor, in fact, aids in breast tumor invasion at least in a subset of carcinomas. Our findings warrant further investigation into the role of this molecule in normal mammary gland and breast tumors and, indeed, in epithelial tissues and tumors where 14-3-3σ is expressed.